Middle East & Africa Crocin Market Size & Outlook
Related Markets
MEA crocin market highlights
- The MEA crocin market generated a revenue of USD 186.5 million in 2023.
- The market is expected to grow at a CAGR of 4% from 2024 to 2030.
- In terms of segment, purity>98% was the largest revenue generating purity in 2023.
- Purity>98% is the most lucrative purity segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 186.5 million |
| Market revenue in 2030 | USD 244.7 million |
| Growth rate | 4% (CAGR from 2023 to 2030) |
| Largest segment | Purity>98% |
| Fastest growing segment | Purity>98% |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Purity>98%, Purity<98% |
| Key market players worldwide | Merck KGaA, GSK PLC, Cipla Ltd DR, Novartis AG ADR, Sanofi SA, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt PLC Ordinary Shares - New, Cayman Chemical, Tokyo Chemical Industry, APExBIO Technology, Wilshire Technologies, Biosynth |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.9% of the global crocin market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,136.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Crocin Market Scope
Crocin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Biosynth | View profile | 501-1000 | Saint Gallen, Sankt Gallen, Switzerland, Europe | https://www.biosynth.com |
| Wilshire Technologies | View profile | 1-10 | Princeton, New Jersey, United States, North America | https://www.wilshiretechnologies.com |
| APExBIO Technology | View profile | 51-100 | Houston, Texas, United States, North America | https://www.apexbt.com |
| Cayman Chemical | View profile | 251-500 | Ann Arbor, Michigan, United States, North America | http://caymanchem.com |
| Tokyo Chemical Industry | View profile | 501-1000 | Chennai, Tamil Nadu, India, Asia | https://www.tcichemicals.com/ |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | https://www.mallinckrodt.com |
| Aurobindo Pharma | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://aurobindo.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Middle East & Africa crocin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crocin market will help companies and investors design strategic landscapes.
Purity>98% was the largest segment with a revenue share of 95.39% in 2023. Horizon Databook has segmented the Middle East & Africa crocin market based on purity>98%, purity<98% covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa, Saudi Arabia, Kuwait, and the UAE are some of the key prospering countries in the Middle East & Africa (MEA) region. The MEA crocin market is expected to be driven by the high prevalence of pain-causing disorders, headaches, & migraines; rise in consumer awareness; and improvements in healthcare infrastructure.
Economic development witnessed in emerging markets, such as South Africa, and high unmet healthcare needs are primary factors expected to drive this market. Moreover, the scope of this region as a major investment avenue has led to the market entry of major pharmaceutical manufacturers.
However, ethical complications, poor infrastructure, and affordability issues may hamper market growth over the forecast period. Moreover, the growing prevalence of various chronic conditions, which require paracetamol and combination drugs to manage pain, is expected to propel the market.
Reasons to subscribe to Middle East & Africa crocin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa crocin market databook
-
Our clientele includes a mix of crocin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa crocin market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa crocin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA crocin market size, by country, 2018-2030 (US$M)
Middle East & Africa Crocin Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
